ArriVent BioPharma was downgraded to Strong Sell after firmonertinib failed its Phase 3 trial, causing shares to drop further. However, new early colorectal cancer data for ARR-217 shows a 44.8% response rate, suggesting some pipeline potential. The company still holds $393 million in cash and investments, supporting ongoing clinical development. Due to these factors, ArriVent has been upgraded to Hold, balancing cautious optimism about future drug prospects against risks in clinical execution and limited valuation upside.
ArriVent BioPharma is the subject of this update, provided here with relevant market data for context. For readers following the health sector, 71 of 150 US health stocks on Pluang rose while 77 fell. Notable movers include HNGE at USD 115.39 with a -4.63% change, RXRX at USD 3.19 with a -4.35% change and 100% buy order activity, and BNGO at USD 1.00 with a -3.85% change. These figures are as of Nov 15, 2026 17:31 WIB.
XRP faces a potential significant correction before the end of 2026, with AI model ChatGPT assigning a 12% probability that the price could crash to $0.50 by December 31. The cryptocurrency recently fell below the key $1 support level amid broader ma...
Since November 4, a crypto market selloff has driven significant losses across major assets: XRP fell 33.07%, Ethereum 30.02%, Solana 30.99%, and Bitcoin 23.61%. XRP experienced the steepest decline, while Bitcoin showed relative resilience. Analyst ...
Binance's Ethereum reserves have dropped to about 2.9 million ETH, the lowest level since 2021, reflecting a nearly 42% decline since mid-2025 amid a prolonged price correction and market selloff. This decline coincides with continued net outflows fr...
Crypto analyst ChartNerd reiterated a price target for XRP between $5 and $8, describing the current price range as a 'Sweet Spot' for potential gains. The analyst emphasized that this opportunity may not last long but did not specify a timeline for ...
Hyperliquid (HYPE) price increased by 3.35% within one hour to $68.42 on Binance spot as of Nov. 15, despite being 1.65% lower than its price 24 hours earlier. During the same hour, $250,000 worth of short positions were liquidated across Binance, By...
